Clinical Trial Update: A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy [Phase 3]

View source ↗

Summary

Phase 3 trial of intravitreal pegaptanib sodium (Macugen) versus sham for tractional retinal detachment and vitreous hemorrhage in proliferative diabetic retino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Macugen (pegaptanib sodium) (pegaptanib sodium)

Snippet

Sponsor: Greater Houston Retina Research | Conditions: Proliferative Diabetic Retinopathy | Phase 3 | Status: WITHDRAWN